Hill & Knowlton hires new US pharmaceutical director

NEW YORK: Paul Oestreicher has joined Hill & Knowlton as the new director of the US health and pharmaceutical practice.

NEW YORK: Paul Oestreicher has joined Hill & Knowlton as the new director of the US health and pharmaceutical practice.

Oestricher, who stepped into the position last Tuesday, most recently led the healthcare practice at DeVries, a position he assumed in July.

He was previously VP of communications for North America at drug company Sanofi-Synthelabo, and has also served as GM of Edelman's Chicago healthcare group.

In a statement, H&K described him as "one of the early architects of direct-to-patient communications."

Oestreicher said he was attracted to H&K because the agency offers "holistic solutions to their clients."

"There is a lot of sector and industry expertise as well as geographic reach," he said, citing collaboration between global offices and practices. "I think I can define healthcare very broadly here."

Oestreicher picks up some of the responsibilities of Paul McDade, who left the agency earlier this year.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.